Dearborn Partners’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$684K Buy
27,078
+2,499
+10% +$63.1K 0.04% 161
2026
Q1
$623K Buy
24,579
+704
+3% +$17.9K 0.03% 165
2025
Q4
$608K Sell
23,875
-257
-1% -$6.55K 0.03% 164
2025
Q3
$616K Buy
24,132
+1,682
+7% +$42.8K 0.03% 163
2025
Q2
$571K Buy
22,450
+1,406
+7% +$35.4K 0.03% 166
2025
Q1
$532K Sell
21,044
-465
-2% -$11.7K 0.03% 163
2024
Q4
$536K Buy
21,509
+11
+0.1% +$276 0.02% 161
2024
Q3
$549K Buy
21,498
+189
+0.9% +$4.77K 0.02% 159
2024
Q2
$528K Buy
21,309
+857
+4% +$21.1K 0.02% 161
2024
Q1
$509K Buy
20,452
+1,025
+5% +$25.5K 0.02% 162
2023
Q4
$487K Buy
+19,427
New +$472K 0.02% 164
2020
Q1
Sell
-13,773
Closed -$382K 229
2019
Q4
$382K Buy
13,773
+3,739
+37% +$104K 0.02% 167
2019
Q3
$278K Buy
+10,034
New +$276K 0.02% 186

Other funds holding IBDT

Dearborn Partners's IBDT Position: Q2 2026 in Review

Dearborn Partners increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 10% in Q2 2026, buying an estimated $63.1K and bringing the position to 27,078 shares worth $684K. The position accounts for 0.04% of the portfolio, ranked #161.

Dearborn Partners first reported a position in IBDT in Q3 2019 and has held it in 13 quarters since. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Dearborn Partners held 27,078 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $684K as of Q2 2026.
  • Dearborn Partners bought 2,499 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $63.1K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.04% of Dearborn Partners's portfolio in Q2 2026, its #161 holding.
  • Dearborn Partners first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q3 2019 and has held it in 13 quarters since.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Dearborn Partners's 13F filing for Q2 2026, filed 13 Aug 2026.